Panel Discussion: Totally Drug Resistant TB Is Here: Are We Too Late? || HGHI

Panel Discussion: Totally Drug Resistant TB is here: Are we too late? || HGHI – Barry Bloom, Ph.D., Harvard School of Public Health (Chair); Sarah Fortune, MD, Harvard School of Public Health; Jeremy Greene, MD, Ph.D., Harvard Medical School; Bob Horsburgh, Ph.D., Boston University; Khisimuzi Mdluli, Ph.D., TB Alliance; Scott Podolsky, MD, Harvard Medical School; Zarir Udwadia, MD, Hunduja National Hospital, Mumbai; and Rob Warren, Ph.D., Stellenbosch University, Cape Town A topical discussion to answer how we have arrived at TDR; to discuss new drugs in the pipeline; to consider the ethical and policy considerations surrounding patient treatment; to predict the spread of TDR, and to mobilize our community to devise a strategy to cure people infected with TDR TB. Sixth Annual New England Tuberculosis Symposium Harvard Global Health Institute June 28th, 2012 The Broad Institute 7 Cambridge Center Cambridge, MA

How the 'Death With Dignity' Law Failed in Massachusetts

Filed under: drug treatment centers in massachusetts

Question 2, which would have allowed doctors to prescribe drugs with which terminally ill patients could end their lives, drew less national attention than Elizabeth Warren's Senate victory. But for those concerned with end-of-life decisions …
Read more on New York Times (blog)

AA benefits vary between sexes

Filed under: drug treatment centers in massachusetts

Two Massachusetts General Hospital (MGH) investigators found that while many factors were helpful to all AA participants, some had stronger effects in men and some in women. For example, avoidance of companions who encourage … whether the benefits …
Read more on Harvard Gazette